CO7160002A2 - Métodos para preparar triazolopiridinas sustituidas - Google Patents

Métodos para preparar triazolopiridinas sustituidas

Info

Publication number
CO7160002A2
CO7160002A2 CO15004251A CO15004251A CO7160002A2 CO 7160002 A2 CO7160002 A2 CO 7160002A2 CO 15004251 A CO15004251 A CO 15004251A CO 15004251 A CO15004251 A CO 15004251A CO 7160002 A2 CO7160002 A2 CO 7160002A2
Authority
CO
Colombia
Prior art keywords
methods
preparing substituted
substituted triazolopyridines
preparing
triazolopyridines
Prior art date
Application number
CO15004251A
Other languages
English (en)
Spanish (es)
Inventor
Volker Klaus Schulze
Franz Josef Mais
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of CO7160002A2 publication Critical patent/CO7160002A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CO15004251A 2012-07-10 2015-01-09 Métodos para preparar triazolopiridinas sustituidas CO7160002A2 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12175640 2012-07-10
EP12185590 2012-09-24
EP13170585 2013-06-05

Publications (1)

Publication Number Publication Date
CO7160002A2 true CO7160002A2 (es) 2015-01-15

Family

ID=48793197

Family Applications (1)

Application Number Title Priority Date Filing Date
CO15004251A CO7160002A2 (es) 2012-07-10 2015-01-09 Métodos para preparar triazolopiridinas sustituidas

Country Status (24)

Country Link
US (1) US9388177B2 (en:Method)
EP (1) EP2872506A1 (en:Method)
JP (1) JP6238979B2 (en:Method)
KR (1) KR20150040845A (en:Method)
CN (1) CN104603136B (en:Method)
AP (1) AP3778A (en:Method)
AU (1) AU2013289381A1 (en:Method)
BR (1) BR112015000308A2 (en:Method)
CA (1) CA2878481A1 (en:Method)
CL (1) CL2015000038A1 (en:Method)
CO (1) CO7160002A2 (en:Method)
CR (1) CR20150006A (en:Method)
DO (1) DOP2015000007A (en:Method)
EA (1) EA027544B1 (en:Method)
HK (1) HK1206731A1 (en:Method)
IL (1) IL236265A (en:Method)
IN (1) IN2015DN00085A (en:Method)
MX (1) MX2015000348A (en:Method)
NZ (1) NZ703020A (en:Method)
PE (1) PE20150354A1 (en:Method)
PH (1) PH12015500061A1 (en:Method)
SG (1) SG11201408419QA (en:Method)
TN (1) TN2015000008A1 (en:Method)
WO (1) WO2014009219A1 (en:Method)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014195276A1 (en) * 2013-06-07 2014-12-11 Bayer Pharma Aktiengesellschaft Substituted triazolopyridines having activity as mps-1 inhibitors
PT3008062T (pt) * 2013-06-11 2017-06-07 Bayer Pharma AG Derivados de profármaco de triazolopiridinas substituídas
WO2014198645A1 (en) 2013-06-11 2014-12-18 Bayer Pharma Aktiengesellschaft Combinations for the treatment of cancer comprising a mps-1 kinase inhibitor and a mitotic inhibitor
EP3283642B1 (en) 2015-04-17 2023-10-11 Netherlands Translational Research Center Holding B.V. Prognostic biomarkers for ttk inhibitor chemotherapy
TW201800408A (zh) 2016-06-15 2018-01-01 拜耳製藥公司 Mps-1抑制劑

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1438973A4 (en) * 2001-10-05 2005-07-13 Ono Pharmaceutical Co MEANS FOR THE TREATMENT OF STRESS-RELATED DISEASES WITH MITOCHONDRIENE BENZODIAZEPINE RECEPTOR ANTAGONISTS
WO2005110410A2 (en) * 2004-05-14 2005-11-24 Abbott Laboratories Kinase inhibitors as therapeutic agents
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
MX2007004179A (es) * 2004-10-07 2007-06-07 Warner Lambert Co Derivados de triazolpiridina como agentes antibacterianos.
US20060194823A1 (en) * 2004-12-22 2006-08-31 Georg Kettschau Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
AR061229A1 (es) * 2006-06-06 2008-08-13 Schering Corp Imidazopirazinas como inhibidores de la proteina quinasa
EP1870416A1 (en) * 2006-06-21 2007-12-26 Bayer Schering Pharma Aktiengesellschaft Sulphonamido-macrocycles as tie2 inhibitors
AU2007291190A1 (en) 2006-08-30 2008-03-06 Cellzome Limited Triazole derivatives as kinase inhibitors
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
MX2010000716A (es) 2007-07-18 2010-03-26 Novartis Ag Compuestos de heteroarilo biciclicos y su uso como inhibidores de cinasa.
EP2212326A1 (en) 2007-08-23 2010-08-04 AstraZeneca AB 2-anilinopurin-8-ones as inhibitors of ttk/mps1 for the treatment of proliferative disorders
CN101878212A (zh) 2007-08-31 2010-11-03 默克雪兰诺有限公司 三唑并吡啶化合物及其作为ask抑制剂的用途
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
US8530689B2 (en) * 2008-05-05 2013-09-10 The Trustees Of The University Of Pennsylvania Processes for the preparation of biphenyl compounds
EP2303890A4 (en) * 2008-06-19 2012-04-11 Progenics Pharm Inc INHIBITORS OF PHOSPHATIDYLINOSITE-3-KINASE
NZ594508A (en) 2009-02-13 2013-12-20 Fovea Pharmaceuticals [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
EP2424537B1 (en) 2009-04-29 2015-07-08 Bayer Intellectual Property GmbH Substituted imidazoquinoxalines
WO2010141360A1 (en) * 2009-06-05 2010-12-09 Merck Sharp & Dohme Corp. Biaryl benzotriazole derivatives
BRPI1009637A2 (pt) * 2009-06-05 2019-04-30 Cephalon, Inc composto, composição e uso de um composto
CN102596932A (zh) 2009-09-04 2012-07-18 拜耳医药股份有限公司 作为酪氨酸苏氨酸激酶抑制剂的取代氨基喹喔啉
EP2343295A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridine derivates
EP2343297A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridines
EP2343294A1 (en) 2009-11-30 2011-07-13 Bayer Schering Pharma AG Substituted triazolopyridines
UY33452A (es) * 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas
WO2012044567A2 (en) * 2010-09-30 2012-04-05 Merck Sharp & Dohme Corp. Imidazole derivatives
EP2699575B1 (en) * 2011-04-21 2015-03-25 Bayer Intellectual Property GmbH Triazolopyridines
WO2012160029A1 (en) * 2011-05-23 2012-11-29 Bayer Intellectual Property Gmbh Substituted triazolopyridines
UA112096C2 (uk) * 2011-12-12 2016-07-25 Байєр Інтеллектуал Проперті Гмбх Заміщені триазолопіридини та їх застосування як інгібіторів ttk

Also Published As

Publication number Publication date
JP6238979B2 (ja) 2017-11-29
EA201590116A1 (ru) 2015-07-30
WO2014009219A1 (en) 2014-01-16
US20150148542A1 (en) 2015-05-28
KR20150040845A (ko) 2015-04-15
CL2015000038A1 (es) 2015-03-13
IL236265A0 (en) 2015-02-26
AP2014008177A0 (en) 2014-12-31
MX2015000348A (es) 2015-04-14
BR112015000308A2 (pt) 2017-06-27
CA2878481A1 (en) 2014-01-16
AU2013289381A1 (en) 2015-01-22
CN104603136A (zh) 2015-05-06
PE20150354A1 (es) 2015-03-21
US9388177B2 (en) 2016-07-12
IL236265A (en) 2017-07-31
EA027544B1 (ru) 2017-08-31
HK1206731A1 (en) 2016-01-15
CN104603136B (zh) 2017-06-27
AP3778A (en) 2016-08-31
DOP2015000007A (es) 2015-02-15
TN2015000008A1 (en) 2016-06-29
IN2015DN00085A (en:Method) 2015-05-29
CR20150006A (es) 2015-02-16
JP2015523372A (ja) 2015-08-13
SG11201408419QA (en) 2015-01-29
PH12015500061A1 (en) 2015-03-02
EP2872506A1 (en) 2015-05-20
NZ703020A (en) 2017-08-25

Similar Documents

Publication Publication Date Title
CR20140463A (es) Compuestos de heterociclilo como inhibidores de mek
CR20130539A (es) Triazolopiridinas
MX2016004933A (es) Inhibidores de pirimidina del fgfr4.
CL2016001733A1 (es) Compuestos intermediarios para la preparación de compuestos derivados de piperidinona como inhibidores mdm2 para el tratamiento de cáncer div. sol. 3415-12.
UY34602A (es) ?Derivados de bencimidazolil- e imidazopiridinil-metilamina?
AR091837A1 (es) Compuestos para inmunoterapia dirigida
UY34472A (es) Derivados modificados de 4-fenil-piridina
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
UY34523A (es) Derivados de betulina
UY34654A (es) Inhibidores de la beta-secretasa
CR20120637A (es) Triazolopiridinas sustituidas
CU20160004A7 (es) Bencil-1 h-pirazolo[3,4-b]piridinas
UY33977A (es) Híbrido de pigmento autoaglutinante.
DOP2015000059A (es) Amino-quinolinas como inhibidores de cinasa
UY35626A (es) Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
DOP2015000060A (es) Profármacos de aminoquinazolina inhibidora de cinasa
LT3495495T (lt) Diagnostiniai žymenys ląstelių proliferacijos sutrikimų gydymui telomerazės inhibitoriais
BR112014026634A2 (pt) direcionador
MX2014015039A (es) Inhibidores de fbx03.
UY34612A (es) ?procedimiento para la preparación de derivados de isoxazolina azetidina quirales como agentes antiparasitarios?.
NI201200195A (es) Procedimiento de preparación de la sal de l - arginina de perindoprilo
BR112015001072A2 (pt) misturas refrigerantes
BR112014027219A2 (pt) método
CO7160002A2 (es) Métodos para preparar triazolopiridinas sustituidas
UY34286A (es) Diagnóstico de vacuna mejorado